Stockreport

Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., March 15, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing product candidates des [Read more]